Home Roche Reports 2021 Financial Results with Ocrelizumab Leading Top 10 Best-Selling Drugs

Roche Reports 2021 Financial Results with Ocrelizumab Leading Top 10 Best-Selling Drugs

Feb 07, 2022 09:53 CST Updated 09:53
Roche

Oncology Drug Research, Development, and Manufacturing

On February 3, Roche released its 2021 financial report, showing total annual revenue of 62.801 billion Swiss francs, a year-on-year increase of 9.3%. Of this, pharmaceutical business revenue was 45.041 billion Swiss francs, a year-on-year increase of 3.1%.

The top 10 best-selling drugs of Roche in 2021 are (Unit: Million Swiss Francs):

According to Roche's financial report, as of now, Roche has 100,920 employees worldwide, including 46,889 in Roche Pharmaceuticals, 39,266 in Roche Diagnostics, 7,711 in Chugai Pharmaceutical, and 7,054 other company personnel.